Home » Clinical Trials » Search Clinical Trials
Therapeutic Areas: Pulmonary/Respiratory Diseases
Clinical Trials: Pleural Effusion
A listing of clinical trials currently looking for volunteers to enroll in Pleural Effusion studies. Click on the closest city to find more detailed information on a research study in your area.
California
Rancho Mirage : Desert Hematology Oncology Medical Group, Inc.
First Line Study of Tamibarotene in Combination for Advanced Non-Small Cell Lung Cancer
Colorado
Denver : National Jewish Medical Center
Impact of Aggressive Versus Standard Drainage Regimen Using a Long Term Indwelling Pleural Catheter
Kansas
Kansas City : Kansas City Cancer Center
First Line Study of Tamibarotene in Combination for Advanced Non-Small Cell Lung Cancer
Maryland
Baltimore : Johns Hopkins University
Impact of Aggressive Versus Standard Drainage Regimen Using a Long Term Indwelling Pleural Catheter
Massachusetts
Boston : Beth Israel Deaconess Medical Center
Impact of Aggressive Versus Standard Drainage Regimen Using a Long Term Indwelling Pleural Catheter
Burlington : Lahey Clinic
Impact of Aggressive Versus Standard Drainage Regimen Using a Long Term Indwelling Pleural Catheter
New Jersey
Hackensack : Hackensack University Medical Center
First Line Study of Tamibarotene in Combination for Advanced Non-Small Cell Lung Cancer
North Carolina
Durham : Duke University Medical Center
Impact of Aggressive Versus Standard Drainage Regimen Using a Long Term Indwelling Pleural Catheter
Texas
Temple : Scott and White Memorial Hospital & Clinic
Alteplase for Treatment of Empyema and Complicated Parapneumonic Effusion
Utah
Salt Lake City : University of Utah
Impact of Aggressive Versus Standard Drainage Regimen Using a Long Term Indwelling Pleural Catheter
Bulgaria
Sofia : Department of Medical Oncology, Specialized Hospital for Active Treatment of Oncological Diseases
First Line Study of Tamibarotene in Combination for Advanced Non-Small Cell Lung Cancer
Varna : Medical Oncology Clinic, Multiprofile Hospital for Active Treatment
First Line Study of Tamibarotene in Combination for Advanced Non-Small Cell Lung Cancer
Veliko Tarnovo : Department of Medical Oncology, Complex Oncology Center
First Line Study of Tamibarotene in Combination for Advanced Non-Small Cell Lung Cancer
China
Beijing : PLA 304 hospital
Intrapleural Bevacizumab and Cisplatin Therapy for Malignant Pleural Effusion Caused by Non-small Cell Lung Cancer
Nanjing : The 81st Hospital of Chinese PLA
Endostar and/or Cisplatin for Treatment of Malignant Pleural Effusion or Ascites
Qingdao : The Affiliated Hospital of Medical College, QingDao University
Endostar and/or Cisplatin for Treatment of Malignant Pleural Effusion or Ascites
Shanghai : Fudan University Shanghai Cancer Center
Endostar and/or Cisplatin for Treatment of Malignant Pleural Effusion or Ascites
India
Anand : M S Patel Cancer Centre, Shree Krishna Hospital
First Line Study of Tamibarotene in Combination for Advanced Non-Small Cell Lung Cancer
Chennai : Dr. Kamakshi Memorial Hospital
First Line Study of Tamibarotene in Combination for Advanced Non-Small Cell Lung Cancer
Coimbatore : G Kuppuswamy Naidu Memorial Hospital, Valvadi Narayanaswamy Cancer Centre
First Line Study of Tamibarotene in Combination for Advanced Non-Small Cell Lung Cancer
Hyderabad : NIZAM's Institute of Medical Sciences
First Line Study of Tamibarotene in Combination for Advanced Non-Small Cell Lung Cancer
Kolkata : Orchid Nursing Home
First Line Study of Tamibarotene in Combination for Advanced Non-Small Cell Lung Cancer
View More »
Nashik : Shatabdi Super Speciality Hospital
First Line Study of Tamibarotene in Combination for Advanced Non-Small Cell Lung Cancer
Nashik : Curie Manavata Cancer Centre
First Line Study of Tamibarotene in Combination for Advanced Non-Small Cell Lung Cancer
Pune : Noble Hospital
First Line Study of Tamibarotene in Combination for Advanced Non-Small Cell Lung Cancer
Mexico
Mexico City : Instituto Nacional de Cancerologia
First Line Study of Tamibarotene in Combination for Advanced Non-Small Cell Lung Cancer
Russian Federation
Arkhangelsk : State Medical Institution: Arkhangelsk Regional Clinical Oncology Center
First Line Study of Tamibarotene in Combination for Advanced Non-Small Cell Lung Cancer
Chelyabinsk : State Therapeutical and Prophylatic Institution: Chelyabinsk Regional Clinical Oncology Center
First Line Study of Tamibarotene in Combination for Advanced Non-Small Cell Lung Cancer
Kursk : State Medical Instituion Kursk Regional Oncology Center
First Line Study of Tamibarotene in Combination for Advanced Non-Small Cell Lung Cancer
Moscow : Non-State Medical Institution: Central Clinical Hospital #2
First Line Study of Tamibarotene in Combination for Advanced Non-Small Cell Lung Cancer
Saint-Pertersburg : St. Petersburg State Healthcare Institution: City Clinical Oncology Center
First Line Study of Tamibarotene in Combination for Advanced Non-Small Cell Lung Cancer
Ukraine
Dnipropetrovsk : Public Institution: Dnipropetrovsk City Multispeciality Clinical Hospital #4
First Line Study of Tamibarotene in Combination for Advanced Non-Small Cell Lung Cancer
Donetsk : Public Clinical Treatment and Prophylaxis Instituion: Donetsk Regional Antitumor Center
First Line Study of Tamibarotene in Combination for Advanced Non-Small Cell Lung Cancer
Ivano-Frankivsk : Ivano-Frankivsk Regional Oncology Center
First Line Study of Tamibarotene in Combination for Advanced Non-Small Cell Lung Cancer
Kharkiv : Public Healthcare Instituion: Kharkiv Regional Clinical Oncology Center
First Line Study of Tamibarotene in Combination for Advanced Non-Small Cell Lung Cancer
Kyiv : Kyiv City Clinical Oncology Center
First Line Study of Tamibarotene in Combination for Advanced Non-Small Cell Lung Cancer
View More »
Uzhhorod : Zakarpattia Regional Clinical Oncology Center
First Line Study of Tamibarotene in Combination for Advanced Non-Small Cell Lung Cancer
